Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Rheumatology · PAMI Syndrome

PAMI Syndrome: A Patient Guide

At a Glance

PAMI syndrome is a rare genetic condition caused by a change in the PSTPIP1 gene. It can cause inflammation while lowering infection-fighting neutrophils, leading to skin ulcers, swollen joints, enlarged liver and spleen, low energy, and growth problems that require coordinated specialist care.

PAMI syndrome is a rare genetic autoinflammatory disorder that fundamentally changes how the innate immune system communicates. In a healthy body, the immune system acts as a disciplined guardian, signaling a response to fight threats and calming down when the danger has passed. For a child (or adult) with PAMI, a specific variation in the PSTPIP1 gene causes dysregulated signaling. The innate immune system remains in a constant state of “high alert,” producing excessive inflammatory proteins that circulate through the blood and affect tissues across the entire body [1].

This persistent state of inflammation leads to a complex and often contradictory set of symptoms. While the body is physically exhausted by overactive immune signals, it paradoxically lacks the necessary tools to fight off external infections. This is because the condition often leads to neutropenia, a shortage of the specific white blood cells needed to combat bacteria. Living with PAMI means navigating this delicate balance: managing a system that is simultaneously overactive yet missing its most critical defenders [2][3].

Because the inflammation is systemic, PAMI is not confined to a single organ or body part. It can manifest as painful skin ulcers, swelling in the joints, and an enlargement of the liver and spleen as these organs are affected by the systemic inflammatory load. It can also impact growth and energy levels, as the body’s resources are diverted away from development and toward maintaining this unnecessary immune response. This wide range of symptoms means that care cannot be managed by a single doctor; it requires a coordinated team of specialists who can look at the blood, the skin, and the internal organs as part of one connected story [1][4].

While the journey toward a diagnosis of PAMI—formerly known as hyperzincemia and hypercalprotectinemia—is often long and filled with uncertainty, receiving the correct name for the condition is a turning point. It allows your medical team to move away from treating individual symptoms and toward addressing the underlying genetic driver. Treatments are highly individualized, and while the path forward requires diligent monitoring and specialized care as the patient grows into adolescence and adulthood, understanding the biology of the condition empowers you to advocate for the targeted therapies and support needed [1][5].

Common questions in this guide

What is PAMI syndrome?
PAMI syndrome is a rare genetic autoinflammatory disorder caused by a specific variation in the PSTPIP1 gene. It causes immune signals to remain overactive, which can affect the blood, skin, joints, liver, spleen, growth, and energy.
How does a PSTPIP1 gene variation affect the body in PAMI syndrome?
The PSTPIP1 gene helps regulate immune signaling. A specific variation can disrupt that communication, leaving inflammatory signals too active and contributing to widespread inflammation and neutropenia.
Why can PAMI cause inflammation and infection risk at the same time?
PAMI can keep inflammatory signals active while also causing neutropenia, or too few neutrophils. Neutrophils are white blood cells that help fight bacterial infections, so the body may be inflamed yet less able to defend against some infections.
What symptoms and body changes can PAMI syndrome cause?
PAMI may cause painful skin ulcers, swollen joints, an enlarged liver or spleen, low energy, and problems with growth. Neutropenia can also make it harder to fight infections, and the combination and severity of symptoms vary from person to person.
What was PAMI syndrome formerly called?
PAMI syndrome was formerly known as hyperzincemia and hypercalprotectinemia. Both names refer to the same rare genetic autoinflammatory disorder.
How is PAMI syndrome managed, and who coordinates care?
Treatment is individualized and may include targeted therapies, supportive care, and close monitoring as the patient grows. Because PAMI can affect blood, skin, joints, and internal organs, care is often coordinated across multiple specialists, with a primary clinician helping connect the plan.

Get notified when new evidence is published on Hyperzincemia and hypercalprotectinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review.

    Mejbri M, Renella R, Candotti F, et al.

    Genes 2023; (14(8)) doi:10.3390/genes14081655.

    PMID: 37628706
  2. 2

    PAMI syndrome: A rare cause that can be easily misdiagnosed.

    Xu XM, Huang H, Ding F, et al.

    American journal of medical genetics. Part A 2021; (185(10)):3074-3082 doi:10.1002/ajmg.a.62367.

    PMID: 34047005
  3. 3

    Strong inflammatory signatures in the neutrophils of PAMI syndrome.

    Zheng W, Fan X, Yang Z, et al.

    Frontiers in immunology 2022; (13()):926087 doi:10.3389/fimmu.2022.926087.

    PMID: 36203570
  4. 4

    Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature.

    Borgia P, Papa R, D'Alessandro M, et al.

    Frontiers in medicine 2021; (8()):759092 doi:10.3389/fmed.2021.759092.

    PMID: 34778321
  5. 5

    Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome.

    Zhang D, Su G, Liu Y, Lai J

    Pediatric rheumatology online journal 2021; (19(1)):151 doi:10.1186/s12969-021-00636-9.

    PMID: 34620178

This page provides general information about PAMI syndrome and its former name, hyperzincemia and hypercalprotectinemia; it is for informational purposes only and does not constitute medical advice. Your healthcare team should interpret symptoms, blood counts, and treatment choices for your individual situation.